"The registration enables Escozine® to be prescribed as a natural bioactive alternative medicine to be used in cancer treatments as well as a treatment for the SARS-CoV-2 (COVID-19) virus, after Medolife performed a safety and efficacy study on COVID-19. This registration in the DR through in-place trade agreements opens the door for distribution and sales in most of Latin America. " https://www.globenewswire.com/news-release/2021/05/04/2222245/0/en/Medolife-Rx-Announces-Historic-Product-Registration-in-Dominican-Republic-Enabling-Escozine-to-Be-Sold-Throughout-Latin-America-as-Natural-Alternative-Cancer-Medicine.html "As of March 2, 2020, population of Latin America and the Caribbean was estimated at more than 652 million" https://en.wikipedia.org/wiki/Latin_America and that is after this "Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations" https://www.otcmarkets.com/stock/QNTA/news/story?e&id=1867919 and there is still this to add into the mix https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163834276 Regardless of FDA approval this will still be making big moves due to even bigger sales in the future. Imo http://medolife.com/order https://quantrx.com/shop